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Review Article
The incidence of preterm births has increased in devel-
oped countries over the past decade, and due to techno-
logical advances, the survival rate of marginally viable 
infants has also increased.1,2 Feeding these very small 
infants is a challenge. Those infants born as early as 22 
weeks gestation spend the entirety of the last trimester 
of pregnancy outside the intrauterine environment.1,2 To 
match intrauterine growth, very low birth weight (<1500 
g) infants have high nutritional requirements.3 However, 
the immaturity of their organ systems can limit the 
safety of providing high nutrient intakes.2 Preterm 
infants experience postnatal growth delay, with the 
resulting growth deficit often not recovered during hos-
pital admission.4 Clinical studies comparing growth 
curves of preterm infants with those of infants in utero 
show a higher proportion of preterm infants small for 
gestational age (weight <10th percentile) at discharge.4-6 
The neonatal admission period is increasingly being 
shown to be the critical time for neurodevelopment.7-9 
Early nutritional practices, specifically increased pro-
tein intake, and improved short-term growth outcomes 
during this time have been associated with beneficial 
long-term growth and neurodevelopment.7-9
Current opinion suggests the aim of feeding preterm 
infants is to replicate the growth and body composition 
seen in utero.3,10 Parenteral nutrition is initiated within 
the first hour and enteral nutrition within the first days of 
life, with an aim to achieve full enteral feeding as soon 
as is clinically possible.3 Both infant formulas and 
human milk (HM) are used in enteral feeding. As HM 
has inadequate energy, protein, and bone minerals to 
support optimal growth in preterm infants weighing 
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Abstract
Objective. This review aimed to investigate the relationship between varying levels of enteral protein intake and 
growth in preterm infants, regardless of feeding method. Data Sources. Electronic databases were searched for 
relevant studies, as were review articles, reference lists, and text books. Study Selection. Trials were included if they 
were randomized or quasirandomized, participants were <37 weeks gestation at birth, and protein intakes were 
intentionally or statistically different between study groups. Trials reporting weight, length, and head circumference 
gains in infants fed formula, human milk, or fortified human milk were included. Data Extraction. Studies were 
categorized by feeding-type and relevant data were extracted into summary tables by one reviewer and cross-
checked by a second. Data Synthesis. A meta-analysis could not be conducted due to extensive variability among 
studies; thus, results were synthesized graphically and narratively. Twenty-four trials met the inclusion criteria and 
were included in a narrative synthesis and 19 in a graphical synthesis of study results. Conclusions. There was extensive 
variability in study design, participant characteristics, and study quality. Nonetheless, results are fairly consistent 
that higher protein intake results in increased growth with graphical representation indicating a potentially linear 
relationship. Additionally, intakes as high as 4.5 g/kg/day were shown to be safe in infants weighing >1000 g.
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<2000 g, the use of human milk fortifiers (HMFs) is 
standard clinical practice.3
The quantity of dietary protein required to enable 
optimal growth in preterm infants remains a contentious 
issue. Recommendations for protein intake vary between 
key bodies (Table 1) and have been revised up over the 
last decade. Early research with protein intakes of 6.0 to 
7.0 g/kg/day resulted in metabolic acidosis, uremia, and 
hyperaminoacidaemia;11 however, the protein was of 
poor quality, and recent reviews suggest this may no 
longer apply to current practice.2,12
Cochrane systematic reviews of growth in “high” 
versus “low” protein formula fed infants12 and infants 
fed fortified versus unfortified HM have been pub-
lished.15 The former12 concluded infants receiving for-
mula with higher protein content had improved weight 
gain. The review compared “high” (3.0-4.0 g/kg/day) 
with “low” (<3.0 g/kg/day) protein intakes and 
excluded trials where comparison groups fell within 
the same range. In a review comparing infants receiv-
ing fortified versus unfortified HM, Kuschel and 
Harding15 found improved weight, length, and head 
circumference (HC) growth. However, the review 
included trials comparing non-isocaloric feeds, 
thereby making it difficult to separate the effects of 
protein and energy. Additionally, neither of these 
Cochrane reviews included studies published since 
1995; therefore, an updated review including the most 
recent research is required. Randomized controlled tri-
als (RCTs) comparing the effects of HMFs with differ-
ent protein concentrations on growth have shown 
inconsistent findings. Additionally, many neonatal 
units use mixed feeding and provide preterm formula 
to infants when the mother’s milk supply is not ade-
quate. A comprehensive systematic review investigat-
ing increased protein and growth including all feeding 
methods and reflecting the mixed feeding approach in 
neonatal units is yet to be published.
The objective of this review is to investigate the rela-
tionship between enteral protein intake and growth in 
preterm infants.
Methods
Types of Studies
Randomized or quasi-randomized controlled trials were 
considered for inclusion in this review.
Types of Participants, Interventions, and 
Outcome Measures
Trials that included preterm infants with birth weight 
less than 2.5 kg were included in this review. Trials that 
compared varying protein intakes in formula, unforti-
fied, or fortified HM fed infants were included. Trials 
primarily investigating parenteral nutrition and quality 
of enteral protein intake were beyond the scope of this 
review. To investigate the relationship between protein 
intake and growth independent of energy, only studies 
that held energy constant between groups were included. 
Similarly, only studies that provided infants with ade-
quate energy to allow protein to be used for tissue accre-
tion (ie, >100 kcal/kg)14 were included. Trials that 
reported outcomes of weight gain, length gain, or HC 
gain were included. The inclusion and exclusion criteria 
are summarized in Table 2. In trials with >2 groups, any 
groups not meeting the review criteria were excluded 
from analysis.
Search Method and Data Extraction
Computerized searches were conducted up to March 30, 
2013. Databases, search terms, and filters used are sum-
marized in Figure 1, and in addition the clinical trials reg-
isters, “clinicaltrials.gov,” and Australian New Zealand 
Table 1. Current Nutrient Recommendations for Enteral Feeding Preterm Infants.
Birth Weight
Protein Intake 
(g/kg/day)
Energy Intake 
(kcal/kg/day)
American Academy of Pediatrics10 800-1200 g 4.0 105-130
1200-1800 g 3.5 105-130
Canadian Pediatric Society13 <1000 g 3.5-4.0 105-135
>1000 g 3.0-3.6 105-135
Tsang et al,14 USA, “growing”—clinically stable 
and gaining weight
ELBW 3.8-4.4 130-150
VLBW 3.4-4.2 110-130
European Society for Paediatric Gastroenterology, 
Hepatology and Nutrition3
<1000 g 4.0-4.5 110-135
1000-1800 g 3.5-4.0 110-135
Abbreviations: ELBW, extremely low birth weight (<1000 g); VLBW, very low birth weight (<1500 g).
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Table 2. Inclusion and Exclusion Criteria for Literature Searches.
Inclusion Criteria Exclusion Criteria
•• Gestational age at birth <37 weeks •• Protein intakes not reported
•• Birth weight <2500 g •• Studies investigating differences in parenteral 
feeding solutions
•• Protein intakes intentionally different between 2 or 
more groups
•• Energy difference >10% relative composition or 
shown to be statistically significantly different
•• Reports comparison of change between groups 
in any or all of the following: weight, length, head 
circumference
•• Energy intake of any group <100 kcal/kg
•• Protein intakes between 2 or more groups are 
shown to be not statistically significantly different
439 Records identified from database 
search
122 From Web of Knowledge
139 From Scopus
144 From Medline Ovid
34 From Cochrane Library 
(CENTRAL)
71 Potentially relevant articles 
identified for full-text screening
24 Trials included in qualitative 
synthesis
12 Formula Studies
5 Weight only
2 Weight & length
5 Weight, length & HC
5 Unfortified/Fortified HM
5 Weight, length & HC
7 Comparison of HMFs
7 Weight, length & HC
369 Records excluded through title 
and abstract screening
151 Duplicates
218 Not relevant (animal studies, 
did not relate to either outcome or 
exposure, not preterm infants, 
interventions post term, clearly not 
RCTs or other publication types)
48 Articles excluded through full -text 
screening using inclusion & exclusion 
criteria
4 Multiple reports of the same trial
16 Protein intakes not different
13 No reported protein intakes
10 Not isocaloric
3 Intervention was parenteral
1 No reported growth data
1 Randomisation not cited
1 Article identified through hand 
searching of reference lists
Figure 1. Flow diagram of search methods.
clinical trials registry were searched for trials in progress. 
A combination of MeSH terms (infant, newborn; infant, 
premature; infant, low birth weight; human milk; dietary 
proteins; infant food; growth) and keywords (preterm; 
neonate; breast milk; protein) were utilized in searches. 
English language filters were applied; however, no limits 
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were placed on year of study. Hand-searching of refer-
ence lists was conducted and review articles and text 
books were used to identify further relevant studies. 
Studies were screened for relevance according to the 
selection criteria (Table 2). Studies were categorized by 
feed-type to facilitate comparison between studies with 
somewhat similar protein quality, and relevant data were 
extracted into summary tables by one reviewer and cross-
checked by a second. A meta-analysis could not be con-
ducted due to extensive variability among studies; thus, 
results have been synthesized graphically and 
narratively.
Methodological Quality
Trials were evaluated for risk of bias according to the 
Academy of Nutrition and Dietetics Quality Criteria 
Checklist for primary research.16 Briefly, this assesses 
trials for relevance to practice and scientific rigour.16 
Individual trials were assessed against quality criteria 
specific for RCTs, with “Yes” or “No” being assigned to 
each criterion, or “Unclear” if the study report lacked 
adequate detail for assessment. A summary outcome of 
“Positive,” “Negative,” or “Neutral” is produced.
Results
The search strategy yielded 439 titles; 71 full-text arti-
cles were reviewed (Figure 1). Forty-eight of these were 
excluded. Characteristics of excluded studies are sum-
marized in Figure 1. Twenty-four trials met the inclusion 
criteria for this review. Twelve trials compared the 
growth of infants fed formula with varying protein 
intakes; 5 compared infants fed unfortified HM with 
protein fortified HM, and 7 trials compared infants fed 
different HMFs resulting in varying protein intakes. All 
studies were published between May 1976 and October 
2012. Trials involving formula-fed infants have been 
carried out throughout this entire period. Conversely, tri-
als assessing the adequacy of unfortified HM were con-
ducted between 1985 and 1990, after which time it was 
thought to be unethical to conduct these comparisons, 
and those comparing HMFs or fortification methods 
have occurred since then (1995-2012). Characteristics 
of included studies are summarized in Tables 3, 4 and 5.
Trials Comparing Groups of Formula-Fed 
Infants
Summary of Studies. Twelve of the included trials com-
pared the growth of infants fed formula with varying 
protein intakes (Table 3).17-28 Protein intakes ranged 
from 1.6 g/kg/day to 4.7 g/kg/day (Table 3). Five trials 
found no statistically significant differences between 
groups for any growth outcomes.17,19,22,27,28 Cooke et al18 
and Darling et al26 found that infants with increased pro-
tein intakes (in both studies an additional 0.8 g/kg/day) 
had a greater rate of daily weight gain compared to con-
trols (8 and 7 g/day greater than the control group, 
respectively). Five further studies showed higher protein 
intake groups had greater rates of fractional weight gain 
compared with controls (3-6 g/kg/day greater than con-
trols).20,21,23-25 Kashyap et al25 and Darling et al26 found 
increased rate of HC growth in infants with higher pro-
tein intakes (0.4 and 0.1 cm/week, respectively, more 
than controls). Darling et al26 demonstrated increased 
growth in the higher protein intake group for all out-
come measures (weight and HC reported above, addi-
tional 0.2 cm/week length gain; P < .01). Three trials 
also included a reference group of HM-fed infants and 
compared their growth with that of formula-fed 
infants.24,27,28 Bell et al24 and Svenningsen et al27 found 
no statistically significant difference in any outcome 
measures between the HM- and formula-fed groups, 
while Raiha et al28 found significantly increased weight 
gain in formula-fed infants compared with HM-fed con-
trols (+5 g/day, P < .05).
Critique of Studies. Random sequence generation and allo-
cation concealment were typically poorly reported in tri-
als finding an effect compared with those showing no 
effect. Conversely, 5 of these trials used a standard oper-
ating procedure for anthropometric measurements, thus 
ensuring consistency and accuracy,20,23-26 compared with 
no clear description of measurement methods in all trials 
showing no effect.18,19,21,22,27,28 Furthermore, only 2 trials 
conducted an intention-to-treat analysis.18,19 The study 
duration (>28 days) was a strength of 6 trials.17,19,21,26-28 
Longer trial duration limits the effect of daily fluid fluc-
tuations on weight gain, enabling meaningful changes in 
length and HC to be observed. The difference in sodium 
content of the formula between comparison groups is a 
limitation of the trials by Cooke et al18 and Bell et al.24 
The change in weight seen in these trials may have been 
due to the influence of sodium on fluid balance rather 
than tissue growth. Supporting this, neither trial showed a 
significant difference in length or HC gain (Table 3). The 
small sample sizes of the trials by Costa-Orvay et al17 and 
Bhatia et al22 may have limited their ability to show a sig-
nificant difference between groups, as both trials showed 
a trend toward increased growth in infants with higher 
protein intakes. The trials by Costa-Orvay et al17 and 
Embleton and Cooke19 did not reach the required sample 
size, thus making them vulnerable to Type II error (see 
Supplementary Table 1, available online at http://gph.
sagepub.com/supplemental).
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Few trials showed significant improvements in mul-
tiple outcome measures, limiting the consistency of this 
evidence. Many of the trials showing significantly 
increased weight gain in higher-protein intake groups 
did show a trend for increased rates of growth in length 
and HC but failed to reach significance.23-25 It may be 
that these trials were underpowered to detect statistically 
significant differences in these growth measures as they 
are more variable than weight. Nine studies did not 
report a power calculation, and all trials that did based 
their sample size on expected effect size of other out-
comes such as nitrogen or fat-free mass accretion.
Given the clinical heterogeneity among the trials, it is 
difficult to draw robust conclusions from this evidence. 
The maturity and size of the infants studied varied 
between trials. Reasonably mature infants were studied 
overall (range = 1130-1958 g). This limits the generaliz-
ability of this evidence to very immature infants (<1000 
g). The selection criteria varied widely between trials 
also, with some including infants with intrauterine 
growth failure or those small for gestational age, while 
others excluded these infants. However, the clinical sta-
bility of infants was relatively uniform. Almost all stud-
ies described their sample as “healthy” or “clinically 
stable” (Table 3). Only one trial21 did not exclude infants 
with respiratory distress or on oxygen/ventilator sup-
port. Again, this limits the generalizability of this evi-
dence to infants who experience multiple medical issues 
associated with premature birth.41 A further difficulty 
encountered when comparing these studies is the varia-
tion in method for calculating rate of growth gain. 
Different calculation methods have been shown to pro-
duce varying results, with some more accurate than oth-
ers.42 However, many studies simply did not report their 
method for calculating growth rate.
The variance in effect size seen may reflect other key 
differences between the trials. The difference in protein 
intake between comparison groups ranged from 0.2 g/
kg/day19 to 2.3 g/kg/day.28 Nine trials compared groups 
with less than 1 g/kg difference in intake (Table 3). 
Thus, differences in protein intake between comparison 
groups may have been too small to show the possible 
effect of increased protein intake in some trials. 
Differences in the composition of trial formulas and 
quality of protein may further contribute to statistical 
heterogeneity. Additionally, the medical management of 
infants also likely varied between trials, as these trials 
were conducted steadily over a period of 35 years and 
standards of care in neonatal intensive care units con-
tinue to improve.
These trials provide some evidence that increased 
enteral protein intake (intakes between 3.5 and 4.5 g/kg/
day) results in increased weight gain of 3 to 6 g/kg/day 
in formula-fed infants, but little evidence suggesting 
increased length or HC growth.
Trials Comparing Infants Fed Unfortified HM 
With Those Fed Protein-Fortified HM
Summary of Studies. Five trials compared infants fed 
unfortified HM with those fed protein-fortified HM.29-33 
These trials achieved similarity in energy intake between 
groups through increased volume31,32 or fat30 of unforti-
fied HM feeds, or natural variation in composition of 
HM.29 All trials showed a trend toward increased weight, 
length, and HC in infants fed protein-fortified HM com-
pared with unfortified HM (Table 4). A statistically sig-
nificantly greater increment of weight gain in infants fed 
higher protein intakes was shown in 3 trials (range of 
3-4 g/kg/day greater than controls).29,31,33 Two of these 
also showed significantly increased length growth in 
infants with higher protein intakes (0.2 and 0.4 cm/week 
more than controls)31,33 and one significantly increased 
HC growth (0.3 cm/week greater than controls, P < 
.02).31
Critique of Studies. The quality of these pre-1991 trials is 
difficult to assess due to lack of adequate reporting of 
trial methods. None reported using random sequence 
generation, and only one adequately concealed group 
allocation,30 introducing the possibility of allocation 
bias. Furthermore, personnel and outcome blinding were 
only described in one trial;30 thus, bias may be intro-
duced during unblinded measurement of outcomes. 
However, it is difficult to blind a trial of this type with-
out changing the caloric density of the control feed as 
nonnutritive substances should not be added to preterm 
infant feeds. Three trials limited measurement error 
through the use of one outcome assessor, standardized 
techniques, and repeated measures 29.31,33 (see Supple-
mentary Table 2, available online at http://gph.sagepub.
com/supplemental).
The 4 trials showing increased growth with increased 
protein intake measured protein intakes through analysis 
of pooled daily samples of each infant’s milk, strength-
ening their findings. The only study showing no effect 
measured milk only once, at the beginning of the trial.32 
The sample size used in this trial was also small (16 
infants) compared to the other trials (34-66 infants; 
Table 4), increasing vulnerability to Type II error. 
Furthermore, the short study duration (7 days) may be 
limiting the ability of the study to show a significant 
effect. The generalizability of this study is also question-
able, as it investigated male infants only. All studies 
were strengthened by their achievement of a substan-
tially different protein intake between groups (range = 
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0.7 g/kg/day to 1.8 g/kg/day) ensuring any potential 
effect of increased protein intake was likely to be seen. 
However, the results of 3 trials may be confounded by 
the inclusion of bone minerals in the HMF.29,31,32 
Polberger et al30 did not report P values for any group 
comparisons, limiting interpretation of these results
This evidence is strongly consistent, with all trials 
showing a trend to increased growth in all outcomes 
measured, with multiple outcomes reaching statistical 
significance in 3 trials. This may in part be due to the 
clinical homogeneity between studies. All trials investi-
gated healthy infants of similar size (mean birth weights = 
1090-1435 g) and maturity at study start (Table 4). The 
effect size is also remarkably consistent between trials 
showing significantly increased growth (weight = +3.8 
to +4.1 g/kg/day; length = +0.35 to +0.36 cm/week) 
with only one study deviating from this.33 This trial was 
conducted earlier than the others, with feed and fortifier 
quality likely to have improved since.
There are quality issues with this evidence, primarily 
due to the age of the trials. However, it is highly consis-
tent; all trials show a trend to increased growth in all 
outcomes measures with none showing the opposite 
trend. Thus, this evidence suggests increased protein 
intake (addition of 0.9-1.0 g/100 mL milk) in HM-fed 
infants does result in increased weight, length, and HC 
growth.
Trials Comparing HMFs Resulting in Different 
Protein Intakes
Summary of Studies. Seven trials compared the growth 
of HM-fed infants fed HMFs or supplements resulting 
in different protein intakes.34-40 All trials used multi-
component HMFs including protein, energy, bone 
minerals, and a variable selection of micronutrients. 
Berseth and Moro were the only 2 trials that showed no 
trend toward better growth in the higher protein intake 
groups.37,40 Four trials showed significantly increased 
rates of fractional weight gain in infants with higher 
protein intakes (range = 3-6 g/kg/day greater than con-
trols).35,36,38,39 Three of these trials also showed signifi-
cantly increased gains in HC with higher protein 
intakes (0.2-0.4 cm/week greater than controls).35,36,39 
Two trials showed a trend toward better length 
growth;34,38 however, in the study by Miller et al34 this 
did not reach statistical significance (0.1 cm/week 
greater than controls; P = .08).
Critique of Studies. The trials are of varying quality. 
Miller et al34 alone reported random sequence genera-
tion, while 3 trials reported adequate concealment of 
group allocation.34,36,40 For some of these studies,37-39 
study quality was primarily limited by inadequate 
reporting of random sequence generation and alloca-
tion concealment. Only 3 trials were satisfactorily 
blinded, possibly introducing bias during outcome 
assessment. However, all but one study reported groups 
to be similar at baseline (Miller et al34 had uneven mul-
tiple births between groups). Furthermore, 4 trials con-
ducted statistical analysis on an intention-to-treat basis. 
This ensured groups remained balanced and thus simi-
lar at baseline, strengthening their results. Three of 
these trials found a significant increase in growth in the 
higher protein intake group (see Supplementary 
Table 3, available online at http://gph.sagepub.com/
supple-mental).
All trials are strengthened by adequate study duration 
(range = 21-74 days). The trial by Miller et al34 was the 
most generalizable as it included healthy, sick, and small 
for gestational age infants. All other trials investigated 
“healthy” infants only. Furthermore, 3 trials34,36,40 
reported accurate protein intakes through analysis of 
HM samples. As it has been shown that assumed intakes 
can deviate from actual intakes significantly,43 the use of 
assumed HM composition values limits the accuracy of 
the protein intakes reported by the other trials, and thus 
the results. The differences in protein intake between 
groups were small (range = 0.2-0.6 g/kg/day), and may 
not have been large enough to show a significant effect, 
despite satisfying the selection criteria to be included in 
this review. However, as many of these trials reported 
protein intakes that meet current recommendations 
(Table 1), assessing the effect of smaller increases in 
protein intake is clinically relevant.
There is some clinical heterogeneity among these tri-
als. The birth weight of infants varied widely (range = 
862-1407 g), as did clinical condition and maturity at 
study initiation (13-25 days postmenstrual age). 
Furthermore, compliance to feeding protocol within and 
between trials was wide-ranging, some infants receiving 
none of the assigned intervention38 while others fully 
completed feeding protocols.35 This may partly explain 
the variance in effect size seen between trials (Table 5). 
Variations in fortifier composition, different fortification 
methods, and diverse standards of care may also contrib-
ute. Overall, however, this evidence is reasonably con-
sistent, as all trials showing significantly improved 
growth rate in one outcome variable also show a trend to 
improved growth in all outcome measures (Table 5). 
Thus, it is unlikely to be simply changes in fluid and fat 
mass confounding the results.
These trials provide evidence that increased pro-
tein intake (additional 0.2-0.6 g/kg/day) results in 
small weight, length, and HC gains in infants fed for-
tified HM.
 by guest on October 16, 2014gph.sagepub.comDownloaded from 
Tonkin et al 17
Discussion
All 3 study categories show increased weight gain in 
infants fed higher protein intakes. When considered 
together and represented graphically, a somewhat linear 
dose–response relationship can be seen (Figure 2). 
However, weight gain increases from below intrauterine 
rates to above are larger in the trials comparing infants 
fed unfortified with fortified HM (Figure 2). This likely 
indicates protein intakes of unfortified HM-fed infants 
are inadequate for growth. This is consistent with the 
Cochrane review of the area, which also concluded 
unfortified HM is inadequate for infants <1500 g.15 
Conversely, in infants fed formula or fortified HM, the 
growth of most comparison groups fell between 15 g/kg/
day and 20 g/kg/day (Figure 2). This may indicate that 
generally protein intakes were adequate; thus, overall 
these studies compare adequate intakes with intakes 
supporting optimal growth. The findings of the Cochrane 
review investigating this in formula-fed infants are con-
sistent with those of the present review: increased weight 
gain with higher protein intake, but little evidence for 
increased length or HC growth.12 Overall, statistically 
significant improvement in length or HC growth was 
shown in only 10 of the 18 studies investigating these 
outcomes. This may be due to the duration of the trials, 
as changes in these outcomes take longer to observe 
compared with weight gain.44
Comparing these trials is limited by variation in protein 
quality, micronutrient composition, and nonnutritive effects 
on growth of different feed types. This variation, along with 
differing medical management,27 energy intakes, race, 
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Figure 2. Relationship between protein intake and weight gain.
Five studies did not report weight gain in g/kg/day and thus were excluded.17,19,26,28,34 Formula studies are indicated with black, unfortified 
versus fortified HM studies with white, and studies comparing different HMFs with grey markers. The solid black line represents the clinically 
used weight gain target of 15 g/kg/day.45 The dashed line represents the recently updated weight gain target that accommodates catch-up 
growth, 20 g/kg/day.46
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clinical stability,22,27,29 and size for gestational age of infants 
studied30,33 may explain the spread of results seen in Figure 
2. This comparison is very clinically relevant however, as 
mixed feeding is a reality in clinical practice. The growth 
achieved in many trials met the clinical growth target of 15 g/
kg/day (Figure 2).45 However, only 4 trials achieved the 
growth target46 required for adequate catch-up growth, to 
prevent the disparity seen in the number of infants small for 
gestational age at discharge (Figure 2). This suggests that 
many of the protein intakes studied remain inadequate for 
truly optimal growth. However, the impact of the substantial 
discrepancies between studies in the calculation of rate of 
weight gain should not be underestimated. Methods used 
ranged from the simplest average of weight over time18 to 
complex statistical modelling.34 Patel et al42 showed large 
differences in the growth estimates produced using different 
calculation methods; thus, this undoubtedly contributes to 
the spread of results seen in Figure 2.
Any benefits of increased protein intake need to be bal-
anced with potential adverse effects due to the immature 
organ systems of these infants. Two formula trials with-
drew participants due to perceived adverse effects of 
higher protein intake. Svenningsen et al27 reported late-
onset metabolic acidosis in 5 infants (4 in higher protein 
intake group), and Raiha et al28 reported 2 infants (both 
higher protein intake group) developed progressive nitro-
gen retention and metabolic acidosis. This may be plausi-
bly explained by the age of these trials and therefore likely 
poorer protein quality of feeds. This effect was not shown 
in the more recent trials with even higher protein intakes. 
Additionally, medical management of preterm infants has 
advanced such that greater clinical and metabolic stability 
can be achieved during feeding.2 Seven other trials 
reported either higher serum urea or elevated plasma 
amino acid concentration in infants with higher protein int
akes.17,19,24,25,31,32,34 These authors report, however, that 
although higher than in control infants, elevated biochemi-
cal parameters were not clinically affecting the health of 
the infant, or resolved without intervention. No studies 
reported increased incidence of necrotizing enterocolitis, 
patent ductus arteriosus, or sepsis in higher protein intake 
groups. The present evidence suggests, therefore, that in 
very low birth weight infants protein intakes up to 4.5 g/
kg/day are well tolerated and do not result in adverse out-
come. However, this evidence does not assess the safety of 
such intakes in the smallest and sickest infants.
The evidence base presented in this review is satis-
factory, as RCTs with moderate risk of bias are included. 
The consistency and generalizability of the evidence is 
good as the included trials represent a number of geo-
graphical regions and thus are highly applicable to 
health care internationally. The outcomes measured rep-
resent increments of growth. Therefore, the small 
improvements shown accumulate over the hospital 
admission to have substantial implications for the 
infant’s overall growth. These results satisfactorily47 
show that infants fed higher protein intakes achieve 
small improvements in weight in the order of 3 to 6 g/
kg/day, length of 0.2 to 0.4 cm/week, and HC of 0.1 to 
0.4 cm/week over infants receiving lower protein. Thus, 
preterm infants with birth weight <1750 g fed HM 
should have it fortified with a multicomponent fortifier 
including protein. It may also be beneficial to increase 
the protein content of HMFs to 1.4 g/100 mL milk, and 
of formulas to 2.4 to 2.9 g/100 mL as standard, as no 
adverse effects of these protein intakes were shown.
The evidence presented here is of less than high quality, 
as many of these trials were conducted before clear guide-
lines for reporting of RCTs were established. Thus, any 
future research needs to be done using adequately random-
ized and blinded trials, with large sample sizes. The small-
est and sickest infants should be included, as currently 
very little research includes this group of preterm infants. 
Furthermore, trials involving HM-fed infants must accu-
rately measure protein intakes through HM composition 
analysis. Importantly, a standardized method for calculat-
ing rate of weight gain needs to be adopted by all research-
ers in the field to facilitate comparison of growth velocity 
between studies. This evidence suggests increased enteral 
protein intake results in increased growth in preterm 
infants. Thus, future research should aim to determine the 
protein intakes that provide not only adequate but also 
truly optimal growth, with a focus on safety.
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